ibane.abasolo@vhir.org
ABASOLO OLAORTUA, IBANE
iMarina ID: 04-81Grup
Direccionament i alliberament farmacològic. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Servei
Oncologia. Hospital Universitari Vall d'Hebron. Passeig de la Vall d'Hebron. Barcelona. 08035
CIBER
-. CIBER de Epidemiología y Salud Pública. Barcelona
Codis d'identificació
Cronologia
gener de 2003
Doctorat: Bioquímica. PhD
Universidad de Navarra
gener de 1998
Titulat superior / Grau: Licenciatura en Biología
Universidad de Navarra
Cronologia
juny de 2009
Investigador principal
Vall d'Hebron Institut de Recerca (VHIR). Direccionament i alliberament farmacològic
2009 -
setembre de 2007
INVESTIGADOR A
CIBER de Epidemiología y Salud Pública. -
2007 -
setembre de 2007
Investigador/a. -
Vall d´Hebron
2007 - 2009
gener de 2007
Investigador post-doctoral en el VHIR. CIBER BIOINGENIERIA BIOMATERIALES Y NANOMEDICINA (CIBER-BBN)
CIBER BIOINGENIERIA BIOMATERIALES Y NANOMEDICINA (CIBER-BBN)
2007 - 2009
gener de 2006
Personal Técnico Investigador. Institut d’Alta Tecnologia - PRBB
Institut d’Alta Tecnologia - PRBB
2006 - 2007
gener de 2005
Personal Técnico Investigador. Universitat Pompeu Fabra
Universitat Pompeu Fabra
2005 - 2006
gener de 2003
Investigador post-doctoral. Fundació Insitut Municipal d'Investigació Mèdica
Fundació Insitut Municipal d'Investigació Mèdica
2003 - 2005
gener de 2000
Investigador Visitante. Northwestern University
Northwestern University
2000 - 2001
gener de 1998
Profesor Colaborador. Universidad de Navarra
Universidad de Navarra
1998 - 2003
gener de 1998
Investigador pre-doctoral. Universidad de Navarra
Universidad de Navarra
1998 - 2003
Reconeixements Investigació
Reconeixements Docents
Temàtiques més freqüents
Temáticas
Projectes participats
Direcció y participació en projectes
IP
NO IP
Grups, xarxes
Activitat docent
Tesi Dirigides
2
Centres
Universitat Autònoma de Barcelona
Universidad Pompeu Fabra
Universitat de Barcelona
Assignatura/Curs
Publicacions en Altmetrics
| 2020 | Zileuton™ loaded in polymer micelles effectively reduce breast Cancer circulatin... | |
| 2020 | Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug De... | |
| 2019 | Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cell... | |
| 2019 | Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Funct... | |
| 2018 | Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cance... | |
| 2018 | Rational Design of a siRNA Delivery System: ALOX5 and Cancer Stem Cells as Thera... | |
| 2018 | Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab funct... | |
| 2018 | AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy agai... | |
| 2018 | Extracellular HMGA1 promotes tumor Invasion and Metastasis in Triple-Negative Br... | |
| 2018 | Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype o... | |
| 2017 | Loss of the EPH receptor B6 contributes to colorectal cancer metastasis | |
| 2016 | Highly Versatile Polyelectrolyte Complexes for Improving the Enzyme Replacement ... | |
| 2016 | Cancer stem cells and personalized cancer nanomedicine | |
| 2016 | Conformational and functional variants of CD44-targeted protein nanoparticles bi... | |
| 2016 | α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intr... | |
| 2016 | Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots... | |
| 2016 | Design of chalcogen-containing norepinephrines: Efficient GPx mimics and strong ... | |
| 2015 | EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Me... | |
| 2015 | Multifunctionalized polyurethane-polyurea nanoparticles: hydrophobically driven ... | |
| 2015 | A novel bio-functional material based on mammalian cell aggresomes | |
| 2015 | Strategies for the production of difficult-to-express full-length eukaryotic pro... | |
| 2015 | Fluorescent CSC models evidence that targeted nanomedicines improve treatment se... | |
| 2015 | Diosgenin-based thio(seleno)ureas and triazolyl glycoconjugates as hybrid drugs.... | |
| 2015 | Polymer Capsules as a Theranostic Tool for a Universal in Vitro Screening Assay ... | |
| 2014 | Intracellular targeting of CD44(+) cells with self-assembling, protein only nano... | |
| 2014 | SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer ce... | |
| 2014 | Ex vivo assessment of polyol coated-iron oxide nanoparticles for MRI diagnosis a... | |
| 2014 | Regulation of protein translation and c-Jun expression by prostate tumor overexp... | |
| 2014 | Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch target... | |
| 2013 | Semisynthesis, Cytotoxic Activity, and Oral Availability of New Lipophilic 9-Sub... | |
| 2013 | Optimization of [C-11] Raclopride Positron Emission Tomographic Rat Studies: Com... | |
| 2013 | Multifunctional nanovesicle-bioactive conjugates prepared by a one-step scalable... | |
| 2013 | Unconventional microbial systems for the cost-efficient production of high-quali... | |
| 2013 | Glutathione-sensitive nanoplatform for monitored intracellular delivery and cont... | |
| 2013 | Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based ... | |
| 2012 | Human SMC2 Protein, a Core Subunit of Human Condensin Complex, Is a Novel Transc... | |
| 2011 | Surface-modified silica nanoparticles for tumor-targeted delivery of camptotheci... | |
| 2009 | Keratin 7 promoter selectively targets transgene expression to normal and neopla... | |
| 2009 | Depressed Glucose Consumption at Reperfusion following Brain Ischemia does not C... | |
| 2009 | FDG PET imaging of Ela1-myc mice reveals major biological differences between pa... | |
| 2007 | Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype i... | |
| 2006 | Adremomedullin prevents apoptosis in prostate cancer cells | |
| 2006 | Netrin1 exerts a chemorepulsive effect on migrating cerebellar interneurons in a... | |
| 2005 | Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeut... | |
| 2004 | Adrenomedullin inhibits prostate cancer cell proliferation through a cAMP-indepe... | |
| 2003 | Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amid... | |
| 2003 | Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 pro... | |
| 2002 | Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostat... | |
| 2001 | Inhibition of 5 alpha-reductase in rat prostate reveals differential regulation ... |
Col·laboracions institucionals darrers 5 anys
